Delivery Order SPE2DB22D3004-SPE2DB25FRQ55
Award Date 7/24/25
Potential Completion Date 7/25/25
Potential Value $4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,950.79 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 pods (Generation 5), 5-count units, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 29, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive process, representing a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. This delivery order falls under...
- The Defense Logistics Agency awarded a $1,372.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 generation 5 pods on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $2,395.34 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this medical device delivery, which supports the federal government's...
- The Defense Logistics Agency (DLA) awarded a $7,826.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 pods. The contract, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-competitive procurement of specialized diabetic medical devices. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and fulfills the delivery order through its corporate office division....
- The Defense Logistics Agency awarded a Delivery Order valued at $3,775.06 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 pods (Generation 5), 5-pack units. The order was competitively awarded without set-aside designation and is scheduled for completion by August 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work from its corporate office location. This delivery order represents a continuation of the company's role as a critical...
- The Defense Logistics Agency awarded a $55,224.29 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 pods on September 15, 2025, with an ultimate completion date of September 16, 2025. The order, which represents a non-competitive delivery order, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $36,377.71 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 generation 5 insulin infusion pump pods. This firm fixed-price delivery order was competitively awarded without a set-aside designation and carries an ultimate completion date of September 3, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,495.17 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 pods, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The award was issued on August 15, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,138.73 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 31, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $50,317.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 generation 5 insulin infusion pods. The contract, issued on August 26, 2025, with completion by August 27, 2025, represents a non-competitive delivery order without set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order falls under the company's...